Respair develops airway management devices that replace traditional inflatable cuffs with soft, pliable baffles, effectively sealing the airway without exerting pressure. This technology addresses the risk of lung complications from ventilator-associated aspiration, which contributes to high mortality rates in critical care patients.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Ventilator-associated aspiration, caused by ineffective sealing of traditional endotracheal tube cuffs, leads to secondary lung complications and contributes to high mortality rates in critical care patients. Current inflatable cuffs can be error-prone and fail to adequately protect the lungs from aspirated contents.
Solution
Respair develops airway management devices that replace traditional inflatable cuffs with soft, pliable baffles. This technology creates a comprehensive seal in the airway without exerting pressure, acting like a stopper to prevent aspiration. By minimizing the risk of aspirated contents entering the lungs, Respair's devices aim to reduce ventilator-associated complications and improve patient outcomes in critical care settings. The core technology originated at the University of Pittsburgh, driven by the need for improved airway protection during ventilation.
Target Audience
The primary users are clinicians and patients in critical care environments, specifically those requiring ventilation and at risk of ventilator-associated complications.
Features
- Soft, pliable baffles that create a comprehensive airway seal
- Cuffless design eliminates the risk of over-inflation and pressure-related trauma
- Material is biocompatible and designed for extended use